# Taro Pharmaceuticals Inc. – FDA Inspection, Jul 29, 2016

Source: https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/48a32949-7f77-49a7-b273-e98b9542286a
Source feed: FDA_Inspections

> FDA inspection 984831 of Taro Pharmaceuticals Inc., July 29, 2016. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 984831
- Company Name: Taro Pharmaceuticals Inc.
- Inspection Date: 2016-07-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1312804 - 2026-03-27
- FDA Inspection 1257703 - 2024-09-20
- [FDA Inspection 1180887 - 2022-09-16](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/5f06f6fb-7c0a-44ca-8fd5-6aad610d4a0c)
- [FDA Inspection 1088553 - 2019-05-03](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/6c8456ba-f9bc-45c1-aab9-d88bf456c31a)
- [FDA Inspection 1001628 - 2017-01-20](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/03164ddc-43fe-4ffd-90c6-1c18d24b8d7d)

Company: https://www.keypedia.com/companies/taro-pharmaceuticals-inc/2072a3d5-a0ae-4bb7-9375-a6406a4fd768

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c